{"pmid":32288968,"pmcid":"PMC7128746","title":"A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV.","text":["A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV.","Sci Bull (Beijing)","Huang, Norden E","Qiao, Fangli","32288968"],"journal":"Sci Bull (Beijing)","authors":["Huang, Norden E","Qiao, Fangli"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32288968","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.scib.2020.02.005","source":"PubMed","topics":["Transmission"],"weight":1,"_version_":1664071627204198400,"score":8.233237,"similar":[{"pmid":32296269,"pmcid":"PMC7157832","title":"Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA?","text":["Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA?","Drugs Ther Perspect","Javed, Bilal","Sarwer, Abdullah","Soto, Erik B","Mashwani, Zia-Ur-Rehman","32296269"],"journal":"Drugs Ther Perspect","authors":["Javed, Bilal","Sarwer, Abdullah","Soto, Erik B","Mashwani, Zia-Ur-Rehman"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32296269","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s40267-020-00726-w","source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"locations":["Pakistan","Italy","Iran","USA"],"countries":["Pakistan","Italy","United States","Iran, Islamic Republic of"],"countries_codes":["PAK|Pakistan","ITA|Italy","USA|United States","IRN|Iran, Islamic Republic of"],"_version_":1664266651266187264,"score":86.940315},{"pmid":32141624,"title":"Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.","text":["Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.","Using the parameterized susceptible-exposed-infectious-recovered model, we simulated the spread dynamics of coronavirus disease 2019 (COVID-19) outbreak and impact of different control measures, conducted the sensitivity analysis to identify the key factor, plotted the trend curve of effective reproductive number (R), and performed data fitting after the simulation. By simulation and data fitting, the model showed the peak existing confirmed cases of 59 769 arriving on 15 February 2020, with the coefficient of determination close to 1 and the fitting bias 3.02%, suggesting high precision of the data-fitting results. More rigorous government control policies were associated with a slower increase in the infected population. Isolation and protective procedures would be less effective as more cases accrue, so the optimization of the treatment plan and the development of specific drugs would be of more importance. There was an upward trend of R in the beginning, followed by a downward trend, a temporary rebound, and another continuous decline. The feature of high infectiousness for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) led to an upward trend, and government measures contributed to the temporary rebound and declines. The declines of R could be exploited as strong evidence for the effectiveness of the interventions. Evidence from the four-phase stringent measures showed that it was significant to ensure early detection, early isolation, early treatment, adequate medical supplies, patients' being admitted to designated hospitals, and comprehensive therapeutic strategy. Collaborative efforts are required to combat the novel coronavirus, focusing on both persistent strict domestic interventions and vigilance against exogenous imported cases.","J Med Virol","Fang, Yaqing","Nie, Yiting","Penny, Marshare","32141624"],"abstract":["Using the parameterized susceptible-exposed-infectious-recovered model, we simulated the spread dynamics of coronavirus disease 2019 (COVID-19) outbreak and impact of different control measures, conducted the sensitivity analysis to identify the key factor, plotted the trend curve of effective reproductive number (R), and performed data fitting after the simulation. By simulation and data fitting, the model showed the peak existing confirmed cases of 59 769 arriving on 15 February 2020, with the coefficient of determination close to 1 and the fitting bias 3.02%, suggesting high precision of the data-fitting results. More rigorous government control policies were associated with a slower increase in the infected population. Isolation and protective procedures would be less effective as more cases accrue, so the optimization of the treatment plan and the development of specific drugs would be of more importance. There was an upward trend of R in the beginning, followed by a downward trend, a temporary rebound, and another continuous decline. The feature of high infectiousness for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) led to an upward trend, and government measures contributed to the temporary rebound and declines. The declines of R could be exploited as strong evidence for the effectiveness of the interventions. Evidence from the four-phase stringent measures showed that it was significant to ensure early detection, early isolation, early treatment, adequate medical supplies, patients' being admitted to designated hospitals, and comprehensive therapeutic strategy. Collaborative efforts are required to combat the novel coronavirus, focusing on both persistent strict domestic interventions and vigilance against exogenous imported cases."],"journal":"J Med Virol","authors":["Fang, Yaqing","Nie, Yiting","Penny, Marshare"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32141624","week":"202010|Mar 02 - Mar 08","doi":"10.1002/jmv.25750","keywords":["COVID-19","SARS-CoV-2","SEIR","basic reproductive number","data fitting","data simulation","effective reproductive number","effectiveness","intervention","sensitivity analysis","transmission"],"source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"_version_":1663352134188400640,"score":81.04618},{"pmid":32175421,"pmcid":"PMC7049028","title":"Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.","text":["Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.","Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).","Ann Transl Med","Yang, Shu","Cao, Peihua","Du, Peipei","Wu, Ziting","Zhuang, Zian","Yang, Lin","Yu, Xuan","Zhou, Qi","Feng, Xixi","Wang, Xiaohui","Li, Weiguo","Liu, Enmei","Chen, Ju","Chen, Yaolong","He, Daihai","32175421"],"abstract":["Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV)."],"journal":"Ann Transl Med","authors":["Yang, Shu","Cao, Peihua","Du, Peipei","Wu, Ziting","Zhuang, Zian","Yang, Lin","Yu, Xuan","Zhou, Qi","Feng, Xixi","Wang, Xiaohui","Li, Weiguo","Liu, Enmei","Chen, Ju","Chen, Yaolong","He, Daihai"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32175421","week":"202012|Mar 16 - Mar 22","doi":"10.21037/atm.2020.02.66","keywords":["2019 novel coronavirus","COVID-19","case fatality rate (CFR)","severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)"],"source":"PubMed","locations":["Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1663352133895847937,"score":69.46409},{"pmid":32246906,"title":"Modelling COVID-19 transmission: from data to intervention.","text":["Modelling COVID-19 transmission: from data to intervention.","Lancet Infect Dis","Jia, Zhongwei","Lu, Zuhong","32246906"],"journal":"Lancet Infect Dis","authors":["Jia, Zhongwei","Lu, Zuhong"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246906","week":"202014|Mar 30 - Apr 05","doi":"10.1016/S1473-3099(20)30258-9","source":"PubMed","topics":["Epidemic Forecasting","Transmission","Prevention"],"weight":1,"_version_":1663352135830470658,"score":59.667843},{"pmid":32234250,"title":"Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study.","text":["Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study.","BACKGROUND: The safety of performing spinal anaesthesia for both patients and anaesthetists alike in the presence of active infection with the novel coronavirus disease 2019 (COVID-19) is unclear. Here, we report the clinical characteristics and outcomes for both patients with COVID-19 and the anaesthetists who provided their spinal anaesthesia. METHODS: Forty-nine patients with radiologically confirmed COVID-19 for Caesarean section or lower-limb surgery undergoing spinal anaesthesia in Zhongnan Hospital, Wuhan, China participated in this retrospective study. Clinical characteristics and perioperative outcomes were recorded. For anaesthesiologists exposed to patients with COVID-19 by providing spinal anaesthesia, the level of personal protective equipment (PPE) used, clinical outcomes (pulmonary CT scans), and confirmed COVID-19 transmission rates (polymerase chain reaction [PCR]) were reviewed. RESULTS: Forty-nine patients with COVID-19 requiring supplementary oxygen before surgery had spinal anaesthesia (ropivacaine 0.75%), chiefly for Caesarean section (45/49 [91%]). Spinal anaesthesia was not associated with cardiorespiratory compromise intraoperatively. No patients subsequently developed severe pneumonia. Of 44 anaesthetists, 37 (84.1%) provided spinal anaesthesia using Level 3 PPE. Coronavirus disease 2019 infection was subsequently confirmed by PCR in 5/44 (11.4%) anaesthetists. One (2.7%) of 37 anaesthetists who wore Level 3 PPE developed PCR-confirmed COVID-19 compared with 4/7 (57.1%) anaesthetists who had Level 1 protection in the operating theatre (relative risk reduction: 95.3% [95% confidence intervals: 63.7-99.4]; P<0.01). CONCLUSIONS: Spinal anaesthesia was delivered safely in patients with active COVID-19 infection, the majority of whom had Caesarean sections. Level 3 PPE appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients.","Br J Anaesth","Zhong, Qi","Liu, Yin Y","Luo, Qiong","Zou, Yu F","Jiang, Hai X","Li, Hui","Zhang, Jing J","Li, Zhen","Yang, Xin","Ma, Min","Tang, Li J","Chen, Ying Y","Zheng, Feng","Ke, Jian J","Zhang, Zong Z","32234250"],"abstract":["BACKGROUND: The safety of performing spinal anaesthesia for both patients and anaesthetists alike in the presence of active infection with the novel coronavirus disease 2019 (COVID-19) is unclear. Here, we report the clinical characteristics and outcomes for both patients with COVID-19 and the anaesthetists who provided their spinal anaesthesia. METHODS: Forty-nine patients with radiologically confirmed COVID-19 for Caesarean section or lower-limb surgery undergoing spinal anaesthesia in Zhongnan Hospital, Wuhan, China participated in this retrospective study. Clinical characteristics and perioperative outcomes were recorded. For anaesthesiologists exposed to patients with COVID-19 by providing spinal anaesthesia, the level of personal protective equipment (PPE) used, clinical outcomes (pulmonary CT scans), and confirmed COVID-19 transmission rates (polymerase chain reaction [PCR]) were reviewed. RESULTS: Forty-nine patients with COVID-19 requiring supplementary oxygen before surgery had spinal anaesthesia (ropivacaine 0.75%), chiefly for Caesarean section (45/49 [91%]). Spinal anaesthesia was not associated with cardiorespiratory compromise intraoperatively. No patients subsequently developed severe pneumonia. Of 44 anaesthetists, 37 (84.1%) provided spinal anaesthesia using Level 3 PPE. Coronavirus disease 2019 infection was subsequently confirmed by PCR in 5/44 (11.4%) anaesthetists. One (2.7%) of 37 anaesthetists who wore Level 3 PPE developed PCR-confirmed COVID-19 compared with 4/7 (57.1%) anaesthetists who had Level 1 protection in the operating theatre (relative risk reduction: 95.3% [95% confidence intervals: 63.7-99.4]; P<0.01). CONCLUSIONS: Spinal anaesthesia was delivered safely in patients with active COVID-19 infection, the majority of whom had Caesarean sections. Level 3 PPE appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients."],"journal":"Br J Anaesth","authors":["Zhong, Qi","Liu, Yin Y","Luo, Qiong","Zou, Yu F","Jiang, Hai X","Li, Hui","Zhang, Jing J","Li, Zhen","Yang, Xin","Ma, Min","Tang, Li J","Chen, Ying Y","Zheng, Feng","Ke, Jian J","Zhang, Zong Z"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234250","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.bja.2020.03.007","keywords":["COVID-19","infection","intra-spinal anaesthesia","perioperative clinical characteristics","surgery"],"source":"PubMed","locations":["China","Wuhan","Zhongnan Hospital","Caesarean"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Transmission"],"weight":1,"e_drugs":["Ropivacaine"],"_version_":1663352135509606400,"score":58.729935}]}